Raymond James Trust’s Clorox CLX Stock Holding History

Raymond James Trust’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$857K	Sell	5,260 -1,342	-20%	-$199K	0.02%	553
2024 Q2	$901K	Buy	6,602 +474	+8%	+$65.8K	0.02%	506
2024 Q1	$938K	Sell	6,128 -633	-9%	-$94.5K	0.02%	493
2023 Q4	$964K	Sell	6,761 -511	-7%	-$68.1K	0.03%	467
2023 Q3	$953K	Buy	7,272 +534	+8%	+$81.2K	0.03%	433
2023 Q2	$1.07M	Sell	6,738 -2,508	-27%	-$405K	0.03%	414
2023 Q1	$1.46M	Sell	9,246 -2,036	-18%	-$305K	0.05%	317
2022 Q4	$1.58M	Buy	11,282 +456	+4%	+$64.7K	0.05%	293
2022 Q3	$1.39M	Buy	10,826 +364	+3%	+$52.5K	0.05%	298
2022 Q2	$1.48M	Buy	10,462 +2,062	+25%	+$295K	0.05%	296
2022 Q1	$1.17M	Buy	8,400 +2,312	+38%	+$354K	0.04%	373
2021 Q4	$1.06M	Sell	6,088 -150	-2%	-$25K	0.03%	412
2021 Q3	$1.03M	Sell	6,238 -449	-7%	-$77.3K	0.03%	397
2021 Q2	$1.2M	Buy	6,687 +1,349	+25%	+$246K	0.04%	347
2021 Q1	$1.03M	Sell	5,338 -172	-3%	-$33.1K	0.04%	363
2020 Q4	$1.11M	Sell	5,510 -218	-4%	-$45.1K	0.04%	334
2020 Q3	$1.2M	Buy	5,728 +15	+0.3%	+$3.34K	0.05%	278
2020 Q2	$1.25M	Sell	5,713 -606	-10%	-$121K	0.06%	258
2020 Q1	$1.09M	Buy	6,319 +194	+3%	+$32.1K	0.06%	253
2019 Q4	$940K	Sell	6,125 -337	-5%	-$50.4K	0.04%	317
2019 Q3	$981K	Sell	6,462 -424	-6%	-$67K	0.05%	303
2019 Q2	$1.05M	Sell	6,886 -240	-3%	-$36.7K	0.06%	279
2019 Q1	$1.14M	Sell	7,126 -93	-1%	-$14.4K	0.07%	257
2018 Q4	$1.11M	Buy	7,219 +657	+10%	+$102K	0.07%	240
2018 Q3	$987K	Buy	6,562 +312	+5%	+$44.3K	0.06%	284
2018 Q2	$845K	Hold	6,250	–	–	0.05%	301
2018 Q1	$832K	Buy	6,250 +214	+4%	+$28.7K	0.06%	270
2017 Q4	$898K	Sell	6,036 -1,017	-14%	-$138K	0.06%	264
2017 Q3	$930K	Sell	7,053 -1,569	-18%	-$211K	0.07%	253
2017 Q2	$1.15M	Buy	8,622 +684	+9%	+$92.3K	0.09%	222
2017 Q1	$1.07M	Buy	7,938 +197	+3%	+$25.5K	0.08%	232
2016 Q4	$929K	Buy	7,741 +224	+3%	+$26.4K	0.07%	242
2016 Q3	$941K	Hold	7,517	–	–	0.08%	228
2016 Q2	$1.04M	Sell	7,517 -9	-0.1%	-$1.17K	0.09%	206
2016 Q1	$949K	Buy	7,526 +2,200	+41%	+$280K	0.09%	220
2015 Q4	$676K	Buy	5,326 +22	+0.4%	+$2.73K	0.06%	279
2015 Q3	$613K	Buy	5,304 +50	+1%	+$5.61K	0.07%	260
2015 Q2	$546K	Buy	5,254 +216	+4%	+$23.3K	0.06%	293
2015 Q1	$556K	Buy	5,038 +345	+7%	+$37.5K	0.06%	292
2014 Q4	$489K	Buy	4,693 +1,820	+63%	+$182K	0.05%	330
2014 Q3	$276K	Buy	+2,873	New	+$260K	0.03%	464

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Raymond James Trust's CLX Position: Q3 2024 in Review

Raymond James Trust reduced its Clorox (CLX) stake by 20% in Q3 2024, selling an estimated $199K and leaving 5,260 shares worth $857K. The position accounts for 0.02% of the portfolio, ranked #553.

Raymond James Trust first reported a position in CLX in Q3 2014 and has held it in 41 quarters since. The position peaked at $1.58M in Q4 2022. 1,151 funds tracked by Wall St. Rank hold CLX as of Q3 2024.

Raymond James Trust held 5,260 shares of Clorox worth $857K as of Q3 2024.
Raymond James Trust sold 1,342 Clorox shares in Q3 2024, an estimated $199K.
Clorox made up 0.02% of Raymond James Trust's portfolio in Q3 2024, its #553 holding.
Raymond James Trust first reported a position in Clorox in Q3 2014 and has held it in 41 quarters since.
Raymond James Trust's Clorox position peaked at $1.58M in Q4 2022.
1,151 funds tracked by Wall St. Rank held Clorox as of Q3 2024.

Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.